Supporting U.S.-based Financial Services Client in their work within the healthcare sector.My responsibilities include:- Building/Maintaining comprehensive financial models for companies across various stages (clinical, small-cap, mid-cap, and large-cap), encompassing financial statement forecasting, revenue projections, and the application of a range of valuation methodologies such as DCF, SOTP, NPV, and competitive analysis.- Tracking catalyst events, deal adjustments, and analyzing consensus data for investment strategies and decisions.- Contributing to specific sections of comprehensive reports and presentations for coverage companies, encompassing diverse report types including initiation reports, company notes, quick takes, event summaries, and other biotech-related notes.- Engaging in conferences and earnings calls, summarizing key takeaways and insights to facilitate informed investment decisions.- Utilizing industry-standard tools and databases such as FactSet, Evaluate Pharma, Blue Matrix, BioMed Tracker, Visible Alpha, and Sec.Edgar.- Additional responsibilities encompass surveys, KOLs, question preparation for conferences and earnings calls, management bios review, healthcare policies, tracking clinical trials, and analyzing patents, among other tasks.

Supported a US-based Sell-Side Investment Bank Client in their work within the healthcare sector- Covered and monitored more than 30 cancer clinical-stage biotechnology companies.- Built comprehensive financial and therapeutic models, which involved analyzing financial statements, forecasting revenue, and applying valuation techniques like DCF and SOTP.- Tracked and updated stakeholders with earnings, valuations, consensus, product pipelines, drug launch projections, collaboration announcements, royalties, milestones adjustments, and various databases.- Prepared materials for annual meetings at leading professional healthcare conferences in the industry, such as ESCO and ASMO.- Conducted patient-based modeling, prescription-based modeling, and product pipeline analysis, and analyzed clinical trial data.- Utilized various platforms, including Bloomberg, FactSet, and publicly accessible healthcare databases like clinical trials databases, PubMed, and the FDA's orange and purple book.

• Created a comparable company analysis sheet by comparing the target company with others of similar size and industry.• Offered different analyses and investment advice for various companies and industries using technical analysis.• Clearly communicated potential investment risks to management in proposal presentations.

• Studied the Indian Automobile Industry in-depth and assessed investment potential in the Electric Vehicle (EV) segment• Examined and evaluated financial statements of 25+ companies in the EV ecosystem, out of which, selected 15 of these to build a fictitious themed fund investment portfolio• Prepared a comprehensive report on the Indian EV market and one-pagers for each selected company for the portfolio

• Conducted in-depth analyses of U.S. and Indian stocks using both Fundamental and Technical methods.• Researched and designed MIS financial reports on 15+ US stocks to assist senior management in accelerating decision-making • Assisted in identifying promising stock options for potential investment.

• Observed and interpreted the price action of securities to predict future trends• Employed a range of indicators to validate trading decisions, enhancing trade confirmation.• Constructed two financial models using DCF and relative valuation methods; projected company statements• Monitored and compiled research reports that provide comprehensive analysis for stocks